Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma
Haematologica
.
2024 Dec 1;109(12):4067-4072.
doi: 10.3324/haematol.2023.283798.
Authors
Johanne M Holst
1
,
Martin B Pedersen
1
,
Marie B Enemark
1
,
Marcus C Hansen
2
,
Patrick R Noerhave
1
,
Trine L Plesner
3
,
Henrik Frederiksen
4
,
Michael B Moeller
5
,
Stephen J Hamilton-Dutoit
6
,
Peter Noergaard
7
,
Bo K Mortensen
8
,
Hans B Ommen
1
,
Jesper Stentoft
1
,
Wayne Tam
9
,
Maja Ludvigsen
1
,
Wing C Chan
10
,
Nicolai J Birkbak
11
,
Giorgio Inghirami
9
,
Francesco D'Amore
12
Affiliations
1
Department of Hematology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus.
2
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Hematology, Odense University Hospital, Odense.
3
Department of Pathology, Rigshospitalet, Copenhagen.
4
Department of Hematology, Odense University Hospital, Odense.
5
Department of Pathology, Odense University Hospital, Odense.
6
Department of Pathology, Aarhus University Hospital, Aarhus.
7
Department of Pathology, Herlev Hospital, Copenhagen.
8
Department of Hematology, Herlev Hospital, Herlev.
9
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York City.
10
Department of Pathology, City of Hope Medical Center, Duarte.
11
Department of Molecular Medicine, Aarhus University Hospital, Aarhus.
12
Department of Hematology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus. frandamo@rm.dk.
PMID:
39049601
PMCID:
PMC11609808
DOI:
10.3324/haematol.2023.283798
No abstract available
Grants and funding
Funding
: This investigation was supported by grants from Aarhus University, iLymph, SEB Pension, the Danish Lymphoma Group, and the Ølufgaard P. N. Kristensen Foundation.